NASDAQ:CARA
Cara Therapeutics
- Stock
locale
United Statesmarket
STOCKSindustry
Biotechnologywebsite
www.caratherapeutics.comipo date
Jan 31, 2014
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and immune cells. The company's lead...Show More
Earnings
Earnings Release in 9 daysEarnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus